Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Latest News about Non/Hallucinogenic Psychedelic Compound

Recent news which mentions Non/Hallucinogenic Psychedelic Compound

Enveric Biosciences Advances Testing Of Its Non-Hallucinogenic Psychedelic
Tickers ENVB NEWS
Tags Cannabis Psychedelics EB/003
From Benzinga
Japanese Pharma Company Sponsors Australian Start Up In Development Of Non-Hallucinogenic Medicines
Tickers DSNKY
Tags Non/Hallucinogenic Psychedelic Compound Benzinga Psylo
From Benzinga
Delix's Non-Hallucinogen Completes Safe Administration To First Clinical Trial Cohort
Tags Market News News Delix Therapeutics
From Benzinga
BetterLife's Non-Hallucinogenic LSD's Clinical Studies, Braxia's Psychedelic Treatments Continue
Tickers BETRF BRAXF
Tags Non/Hallucinogenic Psychedelic Compound Benzinga BRAXF
From Benzinga
Psychedelics For Treating Depression: New Research Finds Key In BDNF Receptor
Tags Benzinga Non/Hallucinogenic Psychedelic Compound depression treatment
From Benzinga
MA, FL And OH Psychedelics Scientists And Educators' Latest Research And Views
Tickers PSYBF
Tags Market News psilocybin therapies News
From Benzinga
Another Win For Non-Hallucinogens: Meet Psilera's Candidates Poised For Clinical Stage Milestone
Tags Psilera Psychedelics Markets
From Benzinga
Mood Disorders Could Get An Alternative Treatment With This Next-Gen, Non-Hallucinogenic Psychedelic
Tickers BETRF
Tags Next/Generation Psychedelics Psychedelics Markets
From Benzinga
BetterLife Engages Canadian Healthcare Investment Firm, Aims For Clinical Trial Programs
Tickers BETRF
Tags Advisory Cannabis Psychedelics
From Benzinga
Ceruvia Lifesciences Begins Dosing Volunteers In Research On Non Hallucinogenic LSD Compound
Tags News LSD program Market News
From Benzinga
Psychedelics & Role Of Memory In Healing Process, New Trial Led By Univ. Of Wisconsin
Tags Market News News Benzinga
From Benzinga
Psychedelics Companies And IPs: An Extended Patent Application To Protect Multiple LSD Derivatives
Tickers BETRF
Tags BETRF U/S/ Patent and Trademark Office Benzinga
From Benzinga
This Company Just Created 3 Brand New Psychedelics—Without The Hallucinogenic Side Effects
Tickers MSSTF
Tags Management Guidance Global
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.